Point72 Hong Kong LTD Seres Therapeutics, Inc. Transaction History

Point72 Hong Kong LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $3,456 - $9,753	1,280 Added 21.86%	7,135 $24,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $10,426 - $14,630	-1,655 Reduced 22.04%	5,855 $42,000
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $45,210 - $85,839	7,510 New	7,510 $63,000
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $27,529 - $113,949	-5,042 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.46 - $24.36 $12,700 - $16,759	688 Added 15.8%	5,042 $120,000

Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $9,660 - $15,819	547 Added 14.37%	4,354 $90,000
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $88,512 - $143,638	3,807 New	3,807 $93,000
Q3 2020 Nov 16, 2020	SELL	$3.74 - $28.74 $2,124 - $16,324	-568 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$3.04 - $6.2 $1,726 - $3,521	568 New	568 $3,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.